Alpha -Tocopherol Ascorbic Acid Beta Carotene Chol
| 證據等級: L5 | 預測適應症: 0 個 |
目錄
- Alpha -Tocopherol Ascorbic Acid Beta Carotene Chol
- Multi-Ingredient Supplement Complex: Repurposing Evaluation Not Feasible
Multi-Ingredient Supplement Complex: Repurposing Evaluation Not Feasible
One-Sentence Summary
This submission contains a complex multi-ingredient formula comprising 14 components — including vitamins, antioxidants, cycloastragenol, and biological extracts such as herring sperm DNA and porcine posterior pituitary gland. The TxGNN model was unable to generate any repurposing predictions because the compound string could not be resolved to a single drug entity in the knowledge graph. With 0 clinical trials, 0 publications, and 0 regulatory licenses retrieved, this case cannot proceed to standard repurposing evaluation.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not available (no regulatory record found) |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only — but no prediction was generated) |
| Market Status | Not Marketed |
| Number of Licenses | 0 |
| Recommended Decision | Hold |
Why No Prediction Was Generated
The drug identifier submitted to the pipeline is not a single chemical entity but a semicolon-separated list of 14 distinct ingredients:
α-Tocopherol · Ascorbic Acid · Beta-Carotene · Cholecalciferol · Cyanocobalamin · Cycloastragenol · Glutathione · Herring Sperm DNA · Omega-3 Fatty Acids · Pantothenic Acid · Riboflavin · Saccharomyces Cerevisiae RNA · Sus Scrofa Pituitary Gland (Posterior) · Thiamine
TxGNN operates on individual DrugBank-mapped entities. Because this compound string could not be resolved to a DrugBank ID, the knowledge graph traversal and deep learning scoring steps were both skipped. As a result, predicted_indications is empty and no downstream evidence collection (clinical trials, literature) was triggered.
Additionally:
- No regulatory record was found in the database (0 licenses).
- No DrugBank ID was matched, blocking MOA retrieval.
- The combination includes non-pharmaceutical biological materials (herring sperm DNA, porcine pituitary gland extract) that fall outside standard drug ontologies.
Safety Considerations
Please refer to the product label or package insert for safety information. No drug interaction data, warnings, or contraindication records were retrieved for this multi-ingredient submission.
Conclusion and Next Steps
Decision: Hold
Rationale: The submission could not be processed because TxGNN requires a single, DrugBank-resolvable active ingredient. A 14-component formula submitted as a concatenated string is outside the model’s input specification, yielding zero predictions and zero evidence.
To proceed, the following is needed:
- Decompose the formula — Submit each active ingredient individually (e.g., Cycloastragenol alone, Omega-3 Fatty Acids alone) to generate per-component TxGNN predictions.
- Identify the primary active ingredient — If there is one ingredient driving the therapeutic hypothesis (e.g., Cycloastragenol for telomere biology), prioritize that candidate for a dedicated Evidence Pack.
- Clarify the product category — Determine whether this product is regulated as a pharmaceutical drug, dietary supplement, or biological extract. If it is a nutraceutical or food supplement, standard drug repurposing methodology does not directly apply.
- Obtain a DrugBank ID for each component to enable knowledge graph mapping.
- Retrieve the product label — If this product was submitted to any regulatory agency, obtain the original product monograph to establish the intended indication and safety profile.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.